Document type
ArticleVersion
Accepted versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/176209
Is availability of artesunate associated with the prognosis of imported malaria in Spain?
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Although there is a lot of aspects we stil need to understand about treatment with artemisinins[1], there is no doubt about their efficacy in treating malaria. Artesunate (AS) has demonstrated its superiority against quinine for treatment of severe malaria in terms of reduction of mortality in different randomized clinical trials performed in endemic countries and subsequent meta-analysis[2-4]. Despite having been established as the first line treatment by WHO and several national guidelines[5,6], its full implementation in non-endemic countries has not been completed.
Subject
Citation
Citation
CAMPRUBÍ FERRER, Daniel, et al. Is availability of artesunate associated with the prognosis of imported malaria in Spain?. Travel Medicine and Infectious Disease. 2020. Vol. 37, num. 101695. ISSN 1477-8939. [consulted: 8 of June of 2026]. Available at: https://hdl.handle.net/2445/176209